# China NMPA Drug Inspection - Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Baiyunshan Pharmaceutical Factory - Albendazole tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guangzhou-baiyunshan-pharmaceutical-group-co-ltd-baiyunshan-pharmaceutical-factory/770f17e1-0cec-4fd8-8132-3d70dccc6716/
Source feed: China

> China NMPA drug inspection for Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Baiyunshan Pharmaceutical Factory published June 17, 2021. Drug: Albendazole tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Baiyunshan Pharmaceutical Factory
- Publication Date: 2021-06-17
- Drug Name: Albendazole tablets
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/guangzhou-baiyunshan-pharmaceutical-group-co-ltd-baiyunshan-pharmaceutical-factory/ccea4422-b643-4b8c-b0a6-781d62bb7724/